Jun-xiu Yu - Nanotechnology

Author Information

Jun Yu is associated with the Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK-Shenzhen Research Institute, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China. Her research primarily focuses on gastrointestinal diseases, including liver diseases, gastric carcinogenesis, and colorectal neoplasia.

Research Contributions

Jun Yu has made significant contributions to the understanding of gut microbiota and its impact on various gastrointestinal diseases. Her recent works include exploring the functional roles of gut microbiota in liver diseases, the role of SARS-CoV-2 non-structural protein in triggering pyroptosis, and the heterogeneity of microbial communities within colorectal neoplasia. Notably, her research extends to understanding the molecular subtypes of gastric cancer and the impacts of gut microbiota on gastrointestinal cancer immunotherapy.

Aliases

Jun Yu is also known by the aliases Jun Yu and Jun-xiu Yu.

Publication and Citation Metrics

Metric	Value
Citation Count	36,000
H-index	95
Paper Count	618

Publications:

The functional role and translational potential of gut microbiota and microbial metabolites in liver diseases

DOI: 10.1111/jgh.15767

Year: 2022

SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1.

DOI: 10.1038/s41418-021-00916-7

Year: 2022

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

DOI: 10.1080/15548627.2020.1797280

Year: 2021

Gastric Microbiota beyond H. pylori: An Emerging Critical Character in Gastric Carcinogenesis

DOI: 10.3390/biomedicines9111680

Year: 2021

Su540 REMOVAL OF HOST DNA ENHANCES METAGENOMICS SEQUENCING SENSITIVITY OF THE MICROBIOTA IN TISSUE BIOPSIES

DOI: 10.1016/S0016-5085(21)02462-8

Year: 2021

Classifying gastric cancer using FLORA reveals clinically relevant molecular subtypes and highlights LINC01614 as a biomarker for patient prognosis

DOI: 10.1038/s41388-021-01743-3

Year: 2021

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT Pathway

DOI: 10.1016/j.jcmgh.2021.08.019

Year: 2021

Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis.

DOI: 10.1053/j.gastro.2021.02.020

Year: 2021

Gut microbiota: impacts on gastrointestinal cancer immunotherapy

DOI: 10.1080/19490976.2020.1869504

Year: 2021

O‐GlcNAcylation inhibits hepatic stellate cell activation

DOI: 10.1111/jgh.15690

Year: 2021

How do Microfluidic Devices Work?

What are Microfluidic Biomedical Devices?

Why is Nanomaterial Analysis Important?

What are the Challenges in Implementing Process Compensation?

Why are Patent Families Important in Nanotechnology?

How Are Thermal Properties Influenced?

How Does Nanotechnology Apply to Air Filtration?

What is Touch Sensitivity in Nanotechnology?

How Does Nanotechnology Benefit from Multidisciplinary Collaboration?

What are Monitor Processes in Nanotechnology?

Partnered Content Networks

Relevant Topics